Instalab

Vitamin B12 Deficiency Treatment: Why Pills Work as Well as Shots for Most People

About 1 in 4 elderly adults has low or borderline-low vitamin B12, and most of them don't know it. The deficiency hides behind symptoms so generic (fatigue, brain fog, tingling hands) that doctors often chase other diagnoses for months before checking a B12 level. And when they do check, the standard blood test misses a meaningful number of cases.

The good news: once you catch it, B12 deficiency is one of the most treatable nutritional problems in medicine. The surprise is how you treat it. Despite decades of tradition favoring injections, randomized trials show that swallowing a high-dose pill works just as well for most people.

Who Runs Low and Why

B12 comes almost exclusively from animal foods: meat, fish, eggs, dairy. Your body stores years' worth in the liver, so deficiency develops slowly. But several common situations speed it up.

Age over 50. As the stomach lining thins with age, it produces less acid and less of a protein called intrinsic factor, both of which are needed to extract B12 from food. Prevalence of low B12 climbs past 20% in adults over 60.

Vegetarian and vegan diets. A review of 40 studies found deficiency rates ranging from 0 to 86.5% among vegetarian adults and elderly, with higher rates consistently seen in vegans than in other vegetarian groups. The takeaway isn't that plant-based diets are unhealthy, but that B12 supplementation on these diets isn't optional.

Metformin use. The Diabetes Prevention Program followed over 2,000 people for 13 years and found that after 5 years, metformin users were roughly twice as likely to have low or borderline B12 levels as placebo users (19.1% vs. 9.5%). The gap narrowed by year 13 (20.3% vs. 15.6%), but each additional year on metformin still raised deficiency risk by about 13%. A separate study of 121 metformin-treated diabetics found 28% were deficient.

Pernicious anemia and malabsorption. An autoimmune condition called pernicious anemia destroys the stomach cells that make intrinsic factor, blocking B12 absorption entirely. This accounts for 15-20% of B12 deficiency cases in the elderly, while "food-cobalamin malabsorption" (the inability to release B12 from food proteins) causes over 60%.

The Symptoms That Get Blamed on Everything Else

B12 deficiency can mimic a dozen other conditions, which is part of why it goes undiagnosed. The clinical picture ranges from mild to severe.

  • Blood changes. Classic megaloblastic anemia (large, immature red blood cells) is the textbook sign, but 28% of B12-deficient patients have completely normal blood counts.
  • Neurological damage. Numbness and tingling in hands and feet, difficulty walking, balance problems. In severe cases, B12 deficiency causes subacute combined degeneration of the spinal cord, visible on MRI as abnormal signals in the posterior columns.
  • Cognitive decline. Slow thinking, memory problems, and attention deficits. Multiple studies have found a negative correlation between B12 status and cognitive function in older adults.
  • Psychiatric symptoms. Depression, irritability, and in rare cases, psychosis. These can be the first and only presenting symptoms.

The critical point: neurological damage from B12 deficiency can become permanent if treatment is delayed. British guidelines explicitly state that when clinical features strongly suggest deficiency, treatment should start immediately, even before test results come back.

Why Your Blood Test Might Say You're Fine When You're Not

The standard serum B12 test measures total vitamin B12 in the blood. The problem is that about 75% of circulating B12 is bound to a protein called haptocorrin and is biologically inactive. Only the 25% bound to transcobalamin (called holotranscobalamin or holoTC) actually enters your cells.

This matters because total B12 can look normal while functional B12 is low. A study of 700 elderly adults found that holoTC had significantly better diagnostic accuracy than total B12 (area under the ROC curve of 0.90 vs. 0.80). When researchers used total B12 alone, 45% of results fell in an indeterminate zone where the test couldn't reliably confirm or rule out deficiency. With holoTC, only 14% were indeterminate.

The most definitive approach combines two types of markers. Normal levels of both methylmalonic acid (MMA) and homocysteine rule out clinically significant B12 deficiency "with virtual certainty," according to a study of over 400 confirmed deficiency cases. MMA is elevated in 98.4% of truly deficient patients, making it the most sensitive single functional marker.

If your vitamin B12 level comes back in the low-normal range (roughly 200-300 pg/mL), a follow-up MMA or holoTC test can clarify whether you have a real functional deficiency or are just on the lower end of normal.

Pills vs. Shots: The Evidence Is Clear

For decades, B12 deficiency meant a series of intramuscular injections. This made intuitive sense for patients who couldn't absorb B12 from their gut. But biology offers a workaround: about 1% of an oral B12 dose gets absorbed through passive diffusion, bypassing intrinsic factor entirely. At high enough doses, that 1% is plenty.

A Cochrane systematic review examined randomized trials comparing oral B12 (1000-2000 mcg daily) with intramuscular injections. The result: both routes produced equivalent improvements in serum B12 levels, hematological markers, and neurological symptoms over 90 days to 4 months.

In one trial, the oral group actually achieved higher serum B12 levels than the injection group at both 2 months (643 vs. 306 pg/mL) and 4 months (1005 vs. 325 pg/mL). Both groups showed neurological improvement.

The evidence is limited (two RCTs, 108 total participants), and the follow-up periods are relatively short. For severe neurological symptoms, many clinicians still start with injections to restore levels quickly, then switch to oral maintenance.

For the vast majority of cases, though, daily oral supplementation in the 1000-2000 mcg range is an effective, cheaper, and more convenient first-line treatment.

British guidelines support oral therapy "provided appropriate doses are taken and compliance is not an issue". Sweden and Canada have prescribed oral B12 routinely for years.

Cyanocobalamin or Methylcobalamin?

You'll find B12 supplements in several forms. Cyanocobalamin is the most studied in clinical trials and the most stable form. Methylcobalamin is marketed as the "active" form your body can use directly without conversion.

In practice, both work. The clinical trials establishing oral B12's equivalence to injections used cyanocobalamin. Your body converts cyanocobalamin to its active forms efficiently. Methylcobalamin may have theoretical advantages for people with certain genetic variants affecting the conversion pathway, but head-to-head trials comparing the two forms for deficiency treatment are lacking.

The dose matters more than the form. At 1000-2000 mcg daily, even the 1% passive absorption delivers 10-20 mcg, well above the 2.4 mcg daily requirement.

What Recovery Looks Like

B12 treatment typically follows a predictable arc. Blood abnormalities like anemia typically improve within the first two months. Energy and fatigue may begin to improve within a similar timeframe.

Neurological symptoms take longer. Numbness and tingling may improve over months, but recovery depends heavily on how long the deficiency persisted before treatment. This is why early detection matters so much: nerve damage caught within six months is usually reversible, while damage present for a year or more may be only partially reversible or permanent.

For metformin users, the Diabetes Prevention Program data showing a dose-dependent relationship between metformin duration and deficiency risk has prompted growing support for periodic B12 screening in long-term metformin patients.

Treating B12 Deficiency Before It Treats You

The pattern across the research is consistent: B12 deficiency is common, undertested, and highly treatable. The groups at highest risk (older adults, plant-based eaters, metformin users) are identifiable. The standard serum B12 test, while useful, misses subclinical deficiency in a meaningful percentage of people.

If you fall into a risk group, or if you've noticed unexplained fatigue, tingling, or cognitive changes, a B12 level is a reasonable starting point. And if you're already taking a B12 supplement, the research supports what you're doing. Just make sure the dose is high enough: the 2.5-25 mcg found in most multivitamins won't correct a true deficiency. You need 1000-2000 mcg daily for that.

No referral needed. Results reviewed by a physician.

References

17 studies
  1. Green R, Allen LH, Bjørke-monsen AL, Et Al.Nature Reviews Disease Primers2017
  2. Vidal-alaball J, Butler CC, Cannings-john R, Et Al.The Cochrane Database of Systematic Reviews2005
  3. Andrès E, Loukili N, Noel E, Et Al.Canadian Medical Association Journal2004